BridgeMD
New treatment option for Dysarthria, Hypokinetic
Official title Listener Training for Improved Intelligibility of People With Parkinson's Disease
ClinicalTrials.gov ID: NCT06815263
What this study is testing
- What it's testing
- Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Primary language is English
- 18 years or older
- medical diagnosis of Parkinson's disease (patient participants)
- speech diagnosis of hyperkinetic dysarthria, exhibiting hallmark characteristics (patient participants)
You likely can't join if
- Severe cognitive impairment
- Less than 18 years of age
- Primary language other than English
The study team makes the final eligibility decision.
Where it's taking place
- Tallahassee, Florida, United States
- Logan, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tallahassee, Florida, United States; Logan, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.